Powered by Blogger.
facebook twitter Youtube

Ripples Advisory News Update's

If you are looking Stock Cash Tips services for Indian Stock Market, then you are at a right place. Our Company experts continuously monitor Indian Share market and fully optimize Share market result for better. Get all the Share market tips solutions with us. Our mission is to help you succeed because we believe in you, your Ideas, and your dreams.

SPH Sine, Alembic & Adia shall hold 51 percent, 44 percent & 5 percent equity respectively in the joint venture.

Shares of Alembic Pharmaceuticals rose 3 percent in the early trade on Wednesday after the company entered into JV agreement with Chinese firms.


The company has entered into a joint venture agreement with SPH SINE Pharmaceutical Laboratories Co Ltd, China & Adia (Shanghai) Pharma Co Ltd, China to promote and sell pharmaceutical products for the Chinese market, as per company's BSE filing.

Initially, this JV will commercialize products manufactured by Alembic Pharmaceuticals and subsequently the JV plans to set up a manufacturing facility in China, it added.

The JV will commercialize products in the Chinese market which has an increasing demand for generic drugs. It will initially launch with a portfolio of oral solids and is expected to widen to other areas like injectable, ophthalmology, dermatology & oncology which are being currently developed and manufactured by Alembic.

SPH Sine, Alembic & Adia shall hold 51 percent, 44 percent & 5 percent equity respectively in the joint venture.

The company is going to announce its Q4FY19 results on May 8. According to Motilal Oswal, the company is likely to report a 2.6 percent fall in its Q4 net profit at Rs 91.3 crore, while sales are expected to go up by 10.8 percent at Rs 945.2 crore.

At 09:22 hrs Alembic Pharmaceuticals was quoting at Rs 561.20, up to Rs 10.10, or 1.83 percent on the BSE.

A Special Offer for a Special Season! Get Stock Cash Tips to start from 2 Days Free Trial Click Here- Stock Market Tips “We Provide Secure, and Smooth Deals You Can Trust”
Share
Tweet
Pin
Share
No comments
Spot gold was up 0.1 percent at $1,285.56 per ounce, as of 0305 GMT.

Gold prices rose to their highest in more than a week on Wednesday as renewed worries over U.S.-China trade dispute and its potential impact on global growth dented risk sentiment, stoking investors towards safe-haven assets.


Spot gold was up 0.1 percent at $1,285.56 per ounce, as of 0305 GMT, after hitting their highest since April 26 at $1,287.08 U.S. gold futures edged 0.1 percent higher to $1,287 an ounce.

"Gold is being supported by risk-aversion buying at the moment. But, there is no change in the underlying momentum in overall sentiment, which seems to be soft," said Jeffrey Halley, senior market analyst, Asia Pacific at OANDA.

MSCI's broadest index of Asia-Pacific shares outside Japan to its lowest level since late March, tracking Wall Street's slide.

U.S. President Donald Trump tweeted on Sunday he would raise tariffs on $200 billion worth of Chinese goods, while Washington accused Beijing of backtracking from commitments made during trade negotiations.

Chinese Vice Premier Liu He will visit the United States on Thursday for trade talks and additional tariffs are set to take effect on Friday if a trade agreement is not reached by then.

"Investments are moving into high-quality government bonds and Japanese yen rather than gold. Gold should remain supported at least if there is no progress in trade talks. But is probably going to test $1,260 levels if the talks go well," Halley said.

While gold has managed to gain as demand for safe-haven assets have risen, prices have not been able to significantly move up despite the given backdrop in global markets.

"Downside risks to growth from higher tariffs and the potential for equity weakness and lower yields should support gold. But the potential upside to the dollar would likely act as a headwind to gold," UBS said in a research note.

While gold staying above $1,280 is encouraging, the extent of the dovish shift in U.S. Federal Reserve's expectations has made gold vulnerable to improvement in the data during a time when physical markets tend to be mostly quieter due to weak Chinese demand, UBS said.

Gold came under pressure last week after the Fed dashed hopes of an interest rate cut this year.

Meanwhile, holdings of SPDR Gold, the world's largest gold-backed exchange-traded fund, saw a slight uptick on Tuesday after a dismal run. Holdings are still at their lowest level since October 2018.

Also, Indians were expected to buy at least 10 percent more gold during the annual Hindu and Jain holy festival of Akshaya Tritiya than a year ago, supporting physical demand in Asia.

Silver was steady at $14.91 an ounce, while platinum gained 0.5 percent to $872.40.

Palladium rose 0.6 percent to $1,335.79 an ounce.

Best Stock Market Tips News Click Here Or Read More- Stock Market Tips
Share
Tweet
Pin
Share
No comments
Citi has kept the neutral call on the stock with a target at Rs 1,460 per share

The brokerages have a mixed rating on Kotak Mahindra Bank after it reported an impressive jump in profits. Jefferies downgraded the stock to Underperform, while CLSA maintained 'buy' rating on the company.


The private lender reported Q4 standalone net profit at Rs 1,407.8 crore against Rs 1,124 crore reported in the same quarter last fiscal.

The net interest income (NII) of the bank rose 18 percent at Rs 3,048 crore against Rs 2,580 crore in Q4FY18.

Gross NPA stood at 2.14 percent versus 2.07 percent, while net NPA was at 0.75 percent versus 0.71 percent, QoQ.

Here what brokerages recommended on Kotak Mahindra Bank post Q4 results:

Morgan Stanley | Rating: Overweight | Target: Rs 1,600

The research house maintained an Overweight call with a target of Rs 1,600 per share. The company's consolidated PAT was 5 percent below estimate, which is mainly driven by lower bank earnings, it said.

The key positive was strong RoEV/higher margin in insurance.

Macquarie | Rating: Outperform | Target: Rs 1,445

Macquarie has maintained Outperform call on the stock with a target at Rs 1,445. According to Macquarie, the consolidated profit was in-line with expectations. The loan growth was modest and lagged retail focussed peers such as HDFC Bank, it added.

A Special Offer for a Special Season! Get Stock Cash Tips to start from 2 Days Free Trial Click Here- Stock Cash Trading Tips “We Provide Secure, and Smooth Deals You Can Trust”

Share
Tweet
Pin
Share
No comments

At 0947 hrs, Jet Airways was quoting Rs 126.95, down 17.19 percent on the BSE.

Shares of Jet Airways plummeted more than 17 percent intraday on May 2 after bidders of the debt-laden airline failed to submit their expression of interest, handing a major blow to the early revival of the airline.



According to a report in The Economic Times, three of the four qualified bidders—TGP Capital, Etihad Airways and Indigo—have not signed the mandatory nondisclosure agreements for due diligence, with less than 10 days remaining for the final submission of bids.

The report added that only National Investment and Infrastructure Fund (NIIF) has been looking into Jet’s accounts and key documents as part of the due diligence.

The bidders have till May 10 to submit their offer for the airline.

At 0947 hours, Jet Airways was quoting Rs 126.95, down 17.19 percent on the BSE.

Take a free trial in Share Markert, We are providing The Indian's Best Stock Market Tips 

Share
Tweet
Pin
Share
No comments
Older Posts
  • 2 Days Free Trial
  • Commodity News
  • Home Ripples Advisory
  • Stock Cash Services

Stock Cash - Free Trial

Stock Cash - Free Trial

Follow Us

  • facebook
  • twitter
  • Google+
  • youtube

Recent posts

Categories

  • Stock Cash
  • Stock cash Tips
  • Stock cash Tips High accuracy

About me

About Me

Created with by ThemeXpose | Distributed by Blogger Templates